Increased colonic CD8+ T-cell responses were detected in LGG-supplemented mice, induction of CD8+ T cells was dependent on toll-like receptor 2-mediated activation, and LGG reduced tumor burden in a mouse intestinal cancer model in a CD8+ T cell-dependent manner (Table 1) (Owens, et al., 2021). This evidence concerns the gene CD8A and neoplasm.